Membrane lipid composition as new antitumor therapeutic target: sphingomyelin synthase (SGMS) at the basis of Minerval® mechanism of action and design of new Minerval®-related drugs

Project Information

MEMBRANELIPIDTHERAPY

Grant agreement ID: 627441

Project terminated

Start date 1 September 2014

End date 2 May 2017

Funded under

• Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)

Total cost € 173 370,60

EU contribution € 173 370,60

Coordinated by

UNIVERSITAT DE LES ILLES BALEARS
Spain